Syndax Pharmaceuticals Inc

NASDAQ:SNDX  
19.81
+0.50 (+2.59%)
4:08:25 PM EDT: $20.25 +0.44 (+2.22%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)987.76M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.3 Million
Adjusted EPS-$0.63
See more estimates
10-Day MA$18.72
50-Day MA$16.21
200-Day MA$19.71
See more pivots

Syndax Pharmaceuticals Inc Stock, NASDAQ:SNDX

35 Gatehouse Drive, Building D, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.419.1400
Number of Employees: 43

Description

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.